Wintermute Biomedical is a global biopharmaceutical company whose sole focus is to develop next-generation antibiotics in order to address the impending threat of antimicrobial resistance (AMR). Wintermute has developed a truly novel antibiotic compound, which will soon be entering clinical trials. Our vision is to make this antibiotic a reality for the millions of people that fall victim to AMR each year.
View Top Employees from Wintermute Biomedical| Website | http://www.wintermutebiomedical.com |
| Revenue | $608000 |
| Employees | 7 (5 on RocketReach) |
| Technologies |
JavaScript,
HTML,
Twitter
+6 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325413 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Wintermute Biomedical employee's phone or email?
Wintermute Biomedical Questions
The Wintermute Biomedical annual revenue was $608000 in 2023.
Thomas Rau is the Founder and Chief Executive Officer of Wintermute Biomedical.
5 people are employed at Wintermute Biomedical.
Wintermute Biomedical is based in Missoula, Montana.
The NAICS codes for Wintermute Biomedical are [325413, 3254, 32, 325, 32541].
The SIC codes for Wintermute Biomedical are [283, 28].
Top Wintermute Biomedical Employees
-
5+5
-
1
-
11
-
1
-
11
Related Companies
